Yes, Adderall is a central nervous system stimulant. It is classified as a Schedule II controlled substance by both the FDA and the DEA, placing it in the same regulatory category as oxycodone and fentanyl due to its high potential for abuse and dependence. Adderall contains a blend of amphetamine salts in a 3:1 ratio of dextroamphetamine to levoamphetamine, and it is approved to treat ADHD and narcolepsy.
What Makes Adderall a Stimulant
Stimulants are drugs that speed up activity in the central nervous system, and Adderall does this by changing the balance of chemical messengers in the brain. Specifically, it increases the levels of dopamine and norepinephrine available between nerve cells. Dopamine plays a central role in motivation, reward, and focus. Norepinephrine helps regulate alertness and attention.
Adderall raises these levels through several routes at once. It blocks the transporters that normally recycle dopamine and norepinephrine back into nerve cells, so more of each chemical stays active longer. It also triggers nerve cells to release extra dopamine from their internal stores and pushes that dopamine outward into the space between cells. On top of that, it slows down an enzyme that breaks these chemicals down inside the cell. The combined result is a significant, sustained boost in signaling that sharpens focus, increases wakefulness, and can elevate mood.
How It Differs From Other Stimulants
Ritalin (methylphenidate) is the other major prescription stimulant used for ADHD, and people often assume the two drugs work the same way. They overlap, but Adderall does more. Ritalin primarily blocks the reuptake of dopamine and norepinephrine, keeping more of what’s already been released in the gap between nerve cells. Adderall does that too, but it also forces additional dopamine out of storage inside the cell and inhibits the enzyme that would otherwise break it down. This multi-pronged action generally makes Adderall a more potent stimulant at comparable doses.
In practice, some people respond better to one than the other. Clinicians often try both before settling on a long-term prescription, since the two drugs affect individuals differently despite targeting similar brain chemistry.
What’s Actually in an Adderall Tablet
Each Adderall tablet contains four amphetamine salts in equal parts: dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate. In a 20 mg tablet, for example, each salt contributes 5 mg. The overall blend delivers three parts dextroamphetamine to one part levoamphetamine. Dextroamphetamine is the more pharmacologically active form and has a stronger effect on dopamine release, while levoamphetamine has a somewhat greater effect on norepinephrine and tends to produce more peripheral effects like increased heart rate.
Immediate-Release vs. Extended-Release
Adderall comes in two formulations. The immediate-release version (Adderall IR) kicks in within 30 to 45 minutes and lasts roughly 4 to 6 hours, meaning most people need to take it two or three times a day. The extended-release version (Adderall XR) uses a capsule with two types of beads: one set dissolves right away, and the second set dissolves about four hours later. This design provides the same 30 to 45 minute onset but extends the total duration to 8 to 12 hours, covering a full school or work day with a single dose.
The choice between the two usually comes down to lifestyle and how symptoms present throughout the day. XR offers convenience and smoother coverage, while IR allows more flexibility to adjust timing or skip an afternoon dose when needed.
Common Side Effects
Because Adderall stimulates the entire nervous system, not just the parts of the brain responsible for focus, it produces a range of side effects. The most frequently reported include decreased appetite, trouble sleeping, dry mouth, and headaches. Weight loss is common, especially in the first few months, because appetite suppression can be significant.
Cardiovascular effects deserve particular attention. Elevated blood pressure and increased heart rate are the most commonly reported heart-related side effects in both short-term and long-term use. In clinical studies of otherwise healthy adults, about 3% experienced cardiovascular effects such as high blood pressure, palpitations, or rapid heart rate. For most healthy people, these changes are modest. But for anyone with an underlying heart condition, structural heart abnormality, or uncontrolled high blood pressure, these shifts carry real risk. People with a history of narrow-angle glaucoma also face potential complications, since the drug’s stimulant properties can increase pressure inside the eye.
Why a Stimulant Helps With ADHD
It seems counterintuitive that a stimulant would help someone who already feels restless or scattered, but the logic makes sense once you understand what ADHD looks like at the neurochemical level. In ADHD, the prefrontal cortex (the part of the brain responsible for planning, impulse control, and sustained attention) tends to be underactive. Dopamine and norepinephrine signaling in this region runs lower than typical.
By boosting these chemical messengers, Adderall brings the prefrontal cortex closer to normal activity levels. The result is better ability to filter distractions, stay on task, and regulate impulses. It doesn’t sedate hyperactivity so much as it gives the brain’s executive control center the fuel it needs to function properly. This is why stimulants remain the first-line treatment for ADHD despite the name sounding like it would make symptoms worse.
Schedule II Status and Abuse Potential
The DEA classifies Adderall as Schedule II, defined as drugs with a high potential for abuse that can lead to severe psychological or physical dependence. This classification places legal restrictions on how the drug is prescribed: no automatic refills, no calling in prescriptions in most states, and limits on how many days’ supply can be dispensed at once.
The abuse potential is real. At doses higher than prescribed, Adderall produces euphoria, heightened energy, and a sense of invincibility, which is why it circulates as a study drug and party drug. Tolerance develops with regular use, meaning higher doses become necessary to achieve the same effect. Physical dependence can develop, and stopping abruptly after prolonged use often produces a crash marked by fatigue, depression, and increased appetite. At therapeutic doses taken as prescribed for a legitimate diagnosis, the risk of addiction is substantially lower, but it never disappears entirely.
The Ongoing Shortage
The United States has faced a nationwide shortage of ADHD medications since 2022. Research published in JAMA Health Forum traced the problem to production cutbacks by manufacturers, which coincided with a steep drop in US imports of raw amphetamine ingredients. The DEA’s aggregate production quotas were not the bottleneck in 2022 or 2023, though the agency did raise the production quota for a related ADHD drug in 2024. For patients, the practical effect has been pharmacies unable to fill prescriptions on time, forcing switches between brands or formulations that can disrupt symptom management.